Moreover, Ki67 staining in samples from metformin-treated diabetic HCC patients revealed that DOCK1Low patients exhibited a lower proportion of Ki67-positive cells compared to that in the DOCK1High group (Fig. 5D). This evidence concerns the gene MKI67 and hepatocellular carcinoma.